World EPA Congress Presentation:
"How AI And Machine Learning Can Improve Patient Access To Orphan Drugs"

11 May 2022
Presentations
May 11, 2022 Vidya Breeveld-Dwarkasing

On March 22 2022 I held this thought-provoking presentation about the use of modern information technologies to aid patient access to orphan drugs at the World EPA congress in Amsterdam.

My conclusion: These technologies could be valuable instruments that help to provide solutions to fill the data gaps in health technology assessments and guide policy decisions. However, since there are many actors involved, to improve patient access to orphan drugs an ecosystem innovation is needed. Unless this is addressed, these modern technologies will not provide solutions that benefit patient access.

World EPA Congress Presentation By Vidya Dwarkasing
World EPA Congress Presentation
World EPA Congress Presentation in Amsterdam - Vidya Dwarkasing
The Orphan Drug Market Access Dilemma - World EPA Congress
World EPA Congress Presentation in Amsterdam By Vidya Dwarkasing
Inequity in patient access Presentation In World EPA Congress
The healthcare system focus (World EPA Congress Presentation)
RWE about a drug's efficacy, guiding reimbursement and clinical practices:
Complexity and Policymaking (World EPA Congress Vidya Dwarkasing)
Complexity and Policymaking
World EPA Congress Presentation
European payers demand RWE to support HTA and reimbursement decisions
BIG DATA vs THE RIGHT DATA – but how?
Innovation is the process...
What is exactly innovation ?
Business Model Innovation
Ecosystem Innovation
Is the ecosystem ready to embrace this approach?
How can AI & Machine learning aid national reimbursement decisions and improve patient access to orphan medicines?
,

Vidya Breeveld-Dwarkasing

Vidya started working as a pricing & reimbursement manager in Pharma in 2010, after a short one-year career as a regulatory affairs manager. Before that, as a trained veterinarian she had an academic career at the Utrecht University, Faculty of veterinary medicine. There she acquired a Ph.D. in Biomedical science while teaching obstetrics and gynecology in farm animals at the herd health department. During her years in Novartis, Abbvie, Sanofi Pasteur-MSD and most recent Sanofi, she acquired extensive experience in public affairs, pricing & market access, team management, incorporate initiatives, training & development, and stakeholder engagement. She is formally qualified to teach at the university level. That also helps her to deploy different training methodologies depending on the team composition and training goals. She is adept at developing access strategies and creating cross-functional alignment to successfully execute reimbursement procedures and product launches in complex circumstances.

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

I accept My Preferences Decline
Privacy Center Privacy Settings Cookie Policy
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

Necessary Analytics Privacy Center Privacy Policy Cookie Policy
These cookies are necessary for the website to function and cannot be switched off in our systems.
Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec
Cloudflare
For perfomance reasons we use Cloudflare as a CDN network. This saves a cookie "__cfduid" to apply security settings on a per-client basis. This cookie is strictly necessary for Cloudflare's security features and cannot be turned off.
  • __cfduid
WooCommerce
We use WooCommerce as a shopping system. For cart and order processing 2 cookies will be stored. This cookies are strictly necessary and can not be turned off.
  • woocommerce_cart_hash
  • woocommerce_items_in_cart
Decline all Services
Accept all Services